scholarly article | Q13442814 |
P2093 | author name string | Juan Wang | |
Xiao Yang | |||
Juan Wu | |||
Xueqing Yu | |||
Wenfang Chen | |||
Xinhui Liu | |||
Youjia Zeng | |||
Jinjin Fan | |||
Xiaorang Feng | |||
P407 | language of work or name | English | Q1860 |
P921 | main subject | acute kidney injury | Q424337 |
P1104 | number of pages | 10 | |
P304 | page(s) | 22-31 | |
P577 | publication date | 2014-02-12 | |
P1433 | published in | Toxicology | Q1666328 |
P1476 | title | Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway | |
P478 | volume | 318 |
Q38274981 | Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment |
Q36756653 | Bardoxolone Methyl Prevents High-Fat Diet-Induced Colon Inflammation in Mice |
Q53653076 | Bardoxolone Methyl Prevents Mesenteric Fat Deposition and Inflammation in High-Fat Diet Mice. |
Q34415403 | Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties |
Q42704487 | Curcumin prevents maleate-induced nephrotoxicity: relation to hemodynamic alterations, oxidative stress, mitochondrial oxygen consumption and activity of respiratory complex I. |
Q40060254 | Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes. |
Q48111922 | Effects of captopril, telmisartan and bardoxolone methyl (CDDO-Me) in ischemia-reperfusion-induced acute kidney injury in rats: an experimental comparative study |
Q39111132 | Heme Oxygenase 1 as a Therapeutic Target in Acute Kidney Injury |
Q36364169 | Integrated transcriptomic and proteomic analyses uncover regulatory roles of Nrf2 in the kidney |
Q41645053 | Keap1 hypomorphism protects against ischemic and obstructive kidney disease |
Q52668596 | Kidney disease models: tools to identify mechanisms and potential therapeutic targets. |
Q34922961 | Lycopene attenuates colistin-induced nephrotoxicity in mice via activation of the Nrf2/HO-1 pathway. |
Q37343636 | Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression. |
Q28384392 | Oxidant Mechanisms in Renal Injury and Disease |
Q47938445 | PGC1α in the kidney |
Q89687493 | Pretreatment with Roxadustat (FG-4592) Attenuates Folic Acid-Induced Kidney Injury through Antiferroptosis via Akt/GSK-3β/Nrf2 Pathway |
Q30278441 | Progression after AKI: Understanding Maladaptive Repair Processes to Predict and Identify Therapeutic Treatments |
Q41326070 | Protective effects of curcumin on acute gentamicin-induced nephrotoxicity in rats |
Q52613060 | Renal aquaporin-4 associated pathology in TG-26 mice. |
Q43086271 | Salutary effect of pre-treatment with an Nrf2 inducer on ischemia reperfusion injury in the rat liver |
Q38757482 | Stop adding insult to injury-identifying and managing risk factors for the progression of acute kidney injury in children |
Search more.